However, targeting autoreactive CD4 T cells has proven difficult in RA, due to the broad range of antigens implicated in disease, lack of a clear cellular hierarchy of disease drivers, and also patient to patient variation (9–13). Here, CD4 is linked to rheumatoid arthritis.